Get Louis Navellier’s “Post-Tariff Recovery Stocks” Report (FREE) Elon predicted UBI, but this company built it. Get in at just $0.30/share and get 100% bonus shares [adv] Get Louis Navellier’s “Post-Tariff Recovery Stocks” Report (FREE) [sponsor] While others panic over tariffs, smart investors are quietly positioning for the rebound. Get the names of 5…
By Blake Brittain (Reuters) -A federal jury in Delaware said on Thursday that biotech company Amgen owes competitor Regeneron more than $406 million for engaging in anticompetitive behavior to increase sales of its cholesterol-reduction drug Repatha at the expense of Regeneron’s rival drug Praluent. The jury agreed with Regeneron that Amgen unlawfully bundled Repatha with…
(Reuters) -Warren Buffett’s Berkshire Hathaway said on Thursday it more than doubled its stake in alcoholic beverages producer Constellation Brands, while selling its holdings in Citigroup and Brazilian fintech lender Nu Holdings. Berkshire disclosed the trades in a regulatory filing detailing its U.S.-listed stock holdings as of March 31. It said its Constellation stake grew…
(Reuters) -Chipmaking equipment maker Applied Materials missed Wall Street estimate for second-quarter revenue on Thursday, against the backdrop of heightened uncertainty around the ongoing trade war and export curbs. Shares of the Santa-Clara, California based company fell 2% in extended trading. For the quarter ended March 31, the company reported revenue of $7.10 billion, while…
By Echo Wang NEW YORK (Reuters) -AI startup Cohere has doubled its annualized revenue since the beginning of the year, driven by growing demand for secure, customized AI tools among enterprise clients in regulated sectors, the company told Reuters. The company has crossed an annualized revenue of $100 million as of May 2025, according to…
